1. Exploring Interactions between Primary Hepatocytes and Non-Parenchymal Cells on Physiological and Pathological Liver Stiffness
   Vaishaali Natarajan et al, 2021, Biology CrossRef
2. High-dose β-carotene exacerbates high-fat/high-sucrose diet-inducible fibrosis in the liver of Mongolian gerbils
   Shinnosuke Kondo et al, 2019, Fundamental Toxicological Sciences CrossRef
3. Factors associated with advanced hepatic fibrosis in patients with various internal diseases: A multicenter community‐based survey
   Takumi Kawaguchi et al, 2018, Hepatology Research CrossRef
4. Association of obesity profiles and metabolic health status with liver injury among US adult population in NHANES 1999–2016
   Jing Huang et al, 2023, Scientific Reports CrossRef
5. A1H NMR-based metabonomic investigation of time-dependent metabolic trajectories in a high salt-induced hypertension rat model
   Linlin Wang et al, 2015, RSC Advances CrossRef
6. Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease
   Jing Liu et al, 2023, Annals of Hepatology CrossRef
7. Blood Test Results of Pregnant COVID-19 Patients: An Updated Case-Control Study
   Guoqiang Sun et al, 2020, Frontiers in Cellular and Infection Microbiology CrossRef
8. Antihypertensive therapy improves insulin resistance and serum levels of interleukin-6 and −10 in spontaneously hypertensive rats with steatohepatitis
   Masaya Kozono et al, 2016, Molecular Medicine Reports CrossRef
9. Tongxinluo improves cognition by decreasing β-amyloid in spontaneous hypertensive rats
   Yu-Lang Fei et al, 2017, Brain Research CrossRef
10. Intestinal Gastrin/CCKBR (Cholecystokinin B Receptor) Ameliorates Salt-Sensitive Hypertension by Inhibiting Intestinal Na + /H + Exchanger 3 Activity Through a PKC (Protein Kinase C)-Mediated NHERF1 and NHERF2 Pathway
    Xiaoliang Jiang et al, 2022, Hypertension CrossRef
11. Metabolomics reveals the defense mechanism of histidine supplementation on high-salt exposure-induced hepatic oxidative stress
    Pengfei Yang et al, 2023, Life Sciences CrossRef
12. Hepatic Fibrosis and Steatosis in Metabolic Syndrome
    Venu Gopala Reddy Gangireddy et al, 2022, Journal of Obesity & Metabolic Syndrome CrossRef
13. Developmental origins of nonalcoholic fatty liver disease as a risk factor for exaggerated metabolic and cardiovascular-renal disease
    Frank T. Spradley et al, 2018, American Journal of Physiology-Endocrinology and Metabolism CrossRef
14. The Importance of Metabolic Syndrome Status for the Risk of Non-Viral Hepatocellular Carcinoma: A Nationwide Population-Based Study
    Yuri Cho et al, 2022, Frontiers in Oncology CrossRef
15. Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
    Ehimen C. Aneni et al, 2015, Journal of Hypertension CrossRef
16. Does Mechanocrine Signaling by Liver Sinusoidal Endothelial Cells Offer New Opportunities for the Development of Anti-fibrotics?
    Sumeyye Soydemir et al, 2020, Frontiers in Medicine CrossRef
17. Antihypertensive effects of the combined extract of Sorghum bicolor, Vigna angularis, and Eleusine coracana in spontaneously hypertensive rats
    Eunwoo Jeong et al, 2024, Scientific Reports CrossRef
18. High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice
    Yuzaburo Uetake et al, 2015, Lipids in Health and Disease CrossRef
19. Chronic Liver Disease and Metabolic Comorbidities in Healthy Young Males Followed for 65 Years: The Manitoba Follow-up Study
    Julia Uhanova et al, 2021, Clinical Gastroenterology and Hepatology CrossRef
20. The antihypertensive effects of Eucommia ulmoides leaf water/ethanol extracts are chlorogenic acid dependent
    Xue-song Wang et al, 2022, Journal of Functional Foods CrossRef
21. High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China
    Xinyan Yu et al, 2021, Annals of Medicine CrossRef
22. Red Quinoa Hydrolysates with Antioxidant Properties Improve Cardiovascular Health in Spontaneously Hypertensive Rats
    Miguel López-Moreno et al, 2023, Antioxidants CrossRef
23. Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension
    Saroj Chakraborty et al, 2018, Cell Reports CrossRef
24. Hyperuricemia Is Associated with Significant Liver Fibrosis in Subjects with Nonalcoholic Fatty Liver Disease, but Not in Subjects without It
    Pei-Chia Yen et al, 2022, Journal of Clinical Medicine CrossRef
25. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007–2016
    Zhenfei Chi et al, 2023, Annals of Hepatology CrossRef
26. Associations of severe liver diseases with cataract using data from UK Biobank: a prospective cohort study
    Chao Chen et al, 2024, eClinicalMedicine CrossRef